Known targets — ChEMBL curated mechanism
ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.52 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 2/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | PPARA | Q07869 | 2/20 | 0.38 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.37 |
| ▸ | FAAH | O00519 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL829599 | 0.91 | DNM1 (0.64) | DNM1NR1I2RECQLGLAHPGD | |
| SCHEMBL7128039 | 0.91 | DNM1 (0.64) | DNM1NR1I2RECQLGLAHPGD | |
| SCHEMBL3780740 | 0.89 | DNM1 (0.68) | DNM1NR1I2RECQLGLAHPGD | |
| SCHEMBL832250 | 0.89 | DNM1 (0.68) | DNM1NR1I2RECQLGLAHPGD | |
| SCHEMBL18604170 | 0.86 | DNM1 (0.46) | DNM1NR1I2RECQLGLAHPGD | |
| Trifluoromethanesulfonic Acid SCHEMBL3782746 | 0.84 | KCNH2 (0.45) | DNM1NR1I2RECQLGLAHPGD | |
| Trifluoromethanesulfonic Acid SCHEMBL3779474 | 0.84 | KCNH2 (0.45) | DNM1NR1I2RECQLGLAHPGD | |
| SCHEMBL31125177 | 0.83 | DNM1 (0.72) | DNM1TSHR | |
| SCHEMBL30616360 | 0.83 | DNM1 (0.72) | DNM1TSHR | |
| SCHEMBL30698153 | 0.83 | DNM1 (0.72) | DNM1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8357822-B2 | Process for producing high-purity chlorophosphite | NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) | 2013-01-22 | — | — | US | disclosed |
| US-20100324337-A1 | PROCESS FOR PRODUCING HIGH-PURITY CHLOROPHOSPHITE | NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) | 2010-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100324337-A1 | PROCESS FOR PRODUCING HIGH-PURITY CHLOROPHOSPHITE | PHOSPHO1, RPP30, PCBP1 | DNM1 3817/4885NR1I2 4678/4885RECQL 3564/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.